1. Home
  2. VFF vs ENTA Comparison

VFF vs ENTA Comparison

Compare VFF & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Village Farms International Inc.

VFF

Village Farms International Inc.

HOLD

Current Price

$3.62

Market Cap

462.1M

Sector

N/A

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$14.23

Market Cap

407.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VFF
ENTA
Founded
1989
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
462.1M
407.5M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
VFF
ENTA
Price
$3.62
$14.23
Analyst Decision
Buy
Strong Buy
Analyst Count
1
6
Target Price
N/A
$20.33
AVG Volume (30 Days)
3.0M
298.3K
Earning Date
11-10-2025
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.19
N/A
Revenue
$351,979,000.00
$65,324,000.00
Revenue This Year
N/A
$2.13
Revenue Next Year
$6.00
$2.74
P/E Ratio
$18.97
N/A
Revenue Growth
56.61
N/A
52 Week Low
$0.45
$4.09
52 Week High
$4.08
$15.34

Technical Indicators

Market Signals
Indicator
VFF
ENTA
Relative Strength Index (RSI) 51.56 72.29
Support Level $3.58 $11.89
Resistance Level $4.04 $14.51
Average True Range (ATR) 0.30 0.85
MACD -0.02 0.13
Stochastic Oscillator 39.29 89.18

Price Performance

Historical Comparison
VFF
ENTA

About VFF Village Farms International Inc.

Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Leli . The company makes majority of its revenue from the Produce segment.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: